Counterpoint Mutual Funds’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$538K Buy
49,382
+10,777
+28% +$135K 0.08% 174
2025
Q4
$499K Buy
38,605
+7,244
+23% +$93K 0.04% 182
2025
Q3
$405K Buy
+31,361
New +$419K 0.03% 214
2025
Q1
Sell
-24,892
Closed -$742K 373
2024
Q4
$742K Sell
24,892
-4,354
-15% -$92.1K 0.09% 75
2024
Q3
$457K Buy
29,246
+17,605
+151% +$319K 0.09% 106
2024
Q2
$199K Sell
11,641
-36,005
-76% -$633K 0.05% 208
2024
Q1
$745K Buy
47,646
+19,489
+69% +$287K 0.18% 8
2023
Q4
$420K Buy
28,157
+20,686
+277% +$277K 0.16% 9
2023
Q3
$121K Buy
+7,471
New +$215K 0.1% 169

Other funds holding NVCR